Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7093-67-6
2. Gly-gly-gly-gly-gly
3. H-gly-gly-gly-gly-gly-oh
4. N-(n-(n-(n-glycylglycyl)glycyl)glycyl)glycine
5. Glycylglycylglycylglycylglycine
6. 2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]acetic Acid
7. Glycine, Glycylglycylglycylglycyl-
8. Chebi:114248
9. Ml48yn34t4
10. Nsc-96353
11. Glycine, N-(n-(n-(n-glycylglycyl)glycyl)glycyl)-
12. Glycine, N-[n-[n-(n-glycylglycyl)glycyl]glycyl]-
13. Tetraglycylglycine
14. Glycyl-glycyl-glycyl-glycyl-glycine
15. Nsc96353
16. Einecs 230-398-3
17. Gly-gly-gly-gly-gly-oh
18. Epitope Id:132954
19. Unii-ml48yn34t4
20. Chembl14390
21. Schembl391028
22. Dtxsid90221161
23. Zinc4545906
24. Mfcd00083696
25. Nsc 96353
26. Akos028110864
27. Hy-w141916
28. Bs-24396
29. Cs-0201707
30. Ft-0739294
31. N-{n-[n-(n-glycylglycyl)glycyl]glycyl}-glycine
32. Q27195645
33. 14-amino-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic Acid
| Molecular Weight | 303.27 g/mol |
|---|---|
| Molecular Formula | C10H17N5O6 |
| XLogP3 | -4.9 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 303.11788328 g/mol |
| Monoisotopic Mass | 303.11788328 g/mol |
| Topological Polar Surface Area | 180 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 424 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Pentaglycine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pentaglycine, including repackagers and relabelers. The FDA regulates Pentaglycine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pentaglycine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pentaglycine supplier is an individual or a company that provides Pentaglycine active pharmaceutical ingredient (API) or Pentaglycine finished formulations upon request. The Pentaglycine suppliers may include Pentaglycine API manufacturers, exporters, distributors and traders.
Pentaglycine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pentaglycine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pentaglycine GMP manufacturer or Pentaglycine GMP API supplier for your needs.
A Pentaglycine CoA (Certificate of Analysis) is a formal document that attests to Pentaglycine's compliance with Pentaglycine specifications and serves as a tool for batch-level quality control.
Pentaglycine CoA mostly includes findings from lab analyses of a specific batch. For each Pentaglycine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pentaglycine may be tested according to a variety of international standards, such as European Pharmacopoeia (Pentaglycine EP), Pentaglycine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pentaglycine USP).
LOOKING FOR A SUPPLIER?
